Výsledky vyhledávání - Olaf Witt
- Zobrazuji výsledky 1 - 20 z 80
- Přejít na další stránku
-
1
-
2
MAPK pathway activation in pilocytic astrocytoma Autor David Jones, Jan Gronych, Peter Lichter, Olaf Witt, Stefan M. Pfister
Vydáno 2011Revisão -
3
-
4
-
5
-
6
-
7
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells Autor Simon Zeuner, Johanna Vollmer, Romain Sigaud, Sina Oppermann, Heike Peterziel, Dina ElHarouni, Ina Oehme, Olaf Witt, Till Milde, Jonas Ecker
Vydáno 2024Artigo -
8
Histone Deacetylase 8 in Neuroblastoma Tumorigenesis Autor Ina Oehme, Hedwig E. Deubzer, Dennis Wegener, Diana Pickert, Jan-Peter Linke, Barbara Hero, Annette Kopp‐Schneider, Frank Westermann, Scott Ulrich, Andreas von Deimling, Matthias Fischer, Olaf Witt
Vydáno 2008Artigo -
9
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines Autor Martin Michaelis, Malte Kleinschmidt, Susanne Barth, Florian Rothweiler, Janina Geiler, Rainer Breitling, Bernd Mayer, Hedwig E. Deubzer, Olaf Witt, Jörg Kreuter, Hans Wilhelm Doerr, Jaroslav Činátl, Jindřich Činátl
Vydáno 2009Artigo -
10
Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival Autor Theresa Thole, Marco Lodrini, Johannes Fabian, Jasmin Wuenschel, Sebastian Pfeil, Thomas Hielscher, Annette Kopp‐Schneider, Ulrike Heinicke, Simone Fulda, Olaf Witt, Angelika Eggert, Matthias Fischer, Hedwig E. Deubzer
Vydáno 2017Artigo -
11
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated Autor Magalie Géraldy, Michael Morgen, Peter Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira, Oliver Koch, Nikolas Gunkel, Aubry K. Miller
Vydáno 2019Artigo -
12
Pediatric low-grade glioma: State-of-the-art and ongoing challenges Autor Jason Fangusaro, David Jones, Roger J. Packer, David H. Gutmann, Till Milde, Olaf Witt, Sabine Mueller, Michael J. Fisher, Jordan R. Hansford, Uri Tabori, Darren Hargrave, Pratiti Bandopadhayay
Vydáno 2023Revisão -
13
Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data Autor Stephanie E. Combs, Kerstin A. Kessel, Klaus Herfarth, Alexandra Jensen, Susanne Oertel, Claudia Blattmann, Swantje Ecker, Angelika Hoess, Eike Martin, Olaf Witt, Oliver Jäkel, Andreas E. Kulozik, Jürgen Debus
Vydáno 2012Artigo -
14
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance Autor Corinna Bingel, E Koeneke, Johannes Ridinger, Annika Bittmann, Martin Sill, Heike Peterziel, Jagoda K. Wrobel, I Rettig, Till Milde, Uta Fernekorn, Frank Weise, Andreas Schober, Olaf Witt, Ina Oehme
Vydáno 2017Artigo -
15
Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance Autor Johannes Ridinger, E Koeneke, Fiona R. Kolbinger, Katharina Koerholz, Siavosh Mahboobi, Lars Hellweg, Nikolas Gunkel, Aubry K. Miller, Heike Peterziel, Peter Schmezer, Anne Hamacher‐Brady, Olaf Witt, Ina Oehme
Vydáno 2018Artigo -
16
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma Autor Markus Brockmann, Evon Poon, Teeara Berry, Anne Carstensen, Hedwig E. Deubzer, Lukas Rycak, Yann Jamin, Khin Thway, Simon P. Robinson, Frederik Roels, Olaf Witt, Matthias Fischer, Louis Chesler, Martin Eilers
Vydáno 2013Artigo -
17
HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth Autor Till Milde, Ina Oehme, Andrey Korshunov, Annette Kopp‐Schneider, Marc Remke, Paul A. Northcott, Hedwig E. Deubzer, Marco Lodrini, Michael D. Taylor, Andreas von Deimling, Stefan M. Pfister, Olaf Witt
Vydáno 2010Artigo -
18
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients Autor Christin Schmidt, Nil A. Schubert, Sebastian Brabetz, Norman Mack, Benjamin Schwalm, Jennifer A. Chan, Florian Selt, Christel Herold‐Mende, Olaf Witt, Till Milde, Stefan M. Pfister, Andrey Korshunov, Marcel Kool
Vydáno 2017Artigo -
19
Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation Autor I Rettig, E Koeneke, Franziska Trippel, Wolf Mueller, Jürgen Burhenne, Annette Kopp‐Schneider, Johannes Fabian, Andreas Schober, Uta Fernekorn, Andreas von Deimling, Hedwig E. Deubzer, Till Milde, Olaf Witt, Ina Oehme
Vydáno 2015Artigo -
20
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors Autor Michael Daskalakis, David Brocks, Yi-Hua Sheng, Md. Saiful Islam, Alzbeta Ressnerova, Yassen Assenov, Till Milde, Ina Oehme, Olaf Witt, Ashish Goyal, Alexander Kühn, Mark Hartmann, Dieter Weichenhan, Manfred Jung, Christoph Plass
Vydáno 2018Revisão
Vyhledávací nástroje:
Související témata
Biology
Cancer research
Gene
Genetics
Medicine
Internal medicine
Cancer
Oncology
Pathology
Glioma
Histone
Cell biology
Biochemistry
Histone deacetylase
Gene expression
Cell culture
DNA methylation
Medulloblastoma
Bioinformatics
Kinase
Astrocytoma
Chemistry
Computational biology
DNA
MAPK/ERK pathway
Mutation
Epigenetics
In vivo
Neuroblastoma
Pharmacology